We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Corning
GLW
$143B
| $80.4M | 0.17% |
2,882,784
-6,100
| -0.2% | -$188K |
|
52
M&T Bank
MTB
$36.2B
| $79.3M | 0.17% |
430,006
+64,736
| +18% | +$12.1M |
|
53
MSCI
MSCI
$40.9B
| $78.2M | 0.17% |
523,212
-130,300
| -20% | -$18.7M |
|
54
Travelers Companies
TRV
$80.2B
| $76.7M | 0.16% |
551,999
+139,862
| +34% | +$19.5M |
|
55
Comcast
CMCSA
$90B
| $76.4M | 0.16% |
2,235,776
+297,646
| +15% | +$11.5M |
|
56
Texas Instruments
TXN
$261B
| $74.6M | 0.16% |
718,097
+112,612
| +19% | +$12.2M |
|
57
S&P Global
SPGI
$120B
| $73.4M | 0.16% |
384,351
+12,068
| +3% | +$2.23M |
|
58
El Paso Energy Capital Trust I
EP.PRC
$223M
| $72.4M | 0.15% |
1,531,152
| – | – |
|
59
BioMarin Pharmaceuticals
BMRN
$12.4B
| $70.6M | 0.15% |
+870,638
| New | +$74.7M |
|
60
Accenture
ACN
$108B
| $65.2M | 0.14% |
424,527
+12,527
| +3% | +$1.98M |
|
61
McCormick & Company Non-Voting
MKC
$14.2B
| $61.7M | 0.13% |
1,160,000
+38,690
| +3% | +$2.03M |
|
62
Medtronic
MDT
$112B
| $61.7M | 0.13% |
768,764
-58,886
| -7% | -$4.86M |
|
63
Teradyne
TER
$59.3B
| $60.8M | 0.13% |
1,330,400
+113,243
| +9% | +$5.18M |
|
64
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $56.9M | 0.12% |
281,516
+58,346
| +26% | +$74.8M |
|
65
Ingevity
NGVT
$2.68B
| $55.1M | 0.12% |
748,075
-88,473
| -11% | -$6.62M |
|
66
LyondellBasell Industries
LYB
$19.2B
| $55.1M | 0.12% |
521,217
+67,840
| +15% | +$7.58M |
|
67
PepsiCo
PEP
$190B
| $54.6M | 0.12% |
500,584
-59,665
| -11% | -$6.79M |
|
68
LCI Industries
LCII
$2.65B
| $54.1M | 0.11% |
519,725
-82,653
| -14% | -$9.49M |
|
|
AGN
69
DELISTED
Allergan plc
AGN
| $53.7M | 0.11% |
319,321
+1,340
| +0.4% | +$225K |
|
70
RTX Corp
RTX
$301B
| $51M | 0.11% |
644,433
-71,421
| -10% | -$5.9M |
|
|
71
Wells Fargo
WFC
$264B
| $50.3M | 0.11% |
958,930
-909,788
| -49% | -$54M |
|
72
Grand Canyon Education
LOPE
$3.98B
| $50M | 0.11% |
476,189
-14,631
| -3% | -$1.41M |
|
73
RBC Bearings
RBC
$18B
| $49.9M | 0.11% |
401,983
-60,180
| -13% | -$7.47M |
|
74
NextEra Energy
NEE
$177B
| $49.4M | 0.1% |
1,209,692
-92,356
| -7% | -$3.56M |
|
75
Euronet Worldwide
EEFT
$2.7B
| $49.1M | 0.1% |
622,238
-27,511
| -4% | -$2.42M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.